Track pegapamodutide in Peptimes™
Pegapamodutide (LY2944876) is a modified peptide. FDA's substance registry lists a chain of 39 amino acids with groups attached to it. (Source: FDA's substance registry (GSRS).)
Is pegapamodutide FDA-approved?
No. Pegapamodutide is investigational: it's being studied in clinical trials and isn't FDA-approved for any use.
Pegapamodutide
Also: OPK-88006, OPK88006, OPK-88003, OPK88003, TT401, LY2944876, LY-2944876
- Status label in the Peptimes Library
- Phase 1 Trials
- Routes in Peptimes
- Subcutaneous
- Updated
- 1 Nov 2026
US regulatory status
FDA status
Not FDA-approved for any use. Drugs@FDA lists no application with pegapamodutide as an active ingredient.
Source: Drugs@FDA, checked 1 Nov 2026
Investigational
Yes.
Source: ClinicalTrials.gov, checked 1 Nov 2026
How to track it in Peptimes
Add pegapamodutide in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Phase 1 Trials”, which describes its investigational status. It isn’t an approval.
- Logging: the amount you took and how you feel.
- Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell pegapamodutide or any other compound.
More sources
- NIH, ClinicalTrials.gov, NCT07512427, checked 1 Nov 2026: a Phase 1/2 study of OPK-88006 sponsored by OPKO Health, recruiting.
- NIH, ClinicalTrials.gov, NCT02119819 and NCT02188303 (LY2944876), and NCT03406377 (OPK-88003), checked 1 Nov 2026: earlier Phase 2 and Phase 1 studies, completed or terminated.
- FDA, Drugs@FDA, checked 1 Nov 2026: no application lists pegapamodutide as an active ingredient.
- FDA, Global Substance Registration System, Pegapamodutide, checked 1 Nov 2026: its 39-amino-acid sequence and the code name LY2944876.